Molecule in Donor Cells May Be Key to Better Outcomes for Transplant Patients

For patients with leukemia, lymphoma, and other blood cancers, a blood or marrow transplant (BMT) can be a potential cure. But when the transplant uses marrow or blood stem cells from a donor, it can have two effects - one harmful and the other helpful. Now, with a five-year, $2.01 million grant from the National Cancer Institute, Xuefang Cao, MD, PhD, Department of Immunology, is leading research aimed at shutting down the bad side effect and increasing the good one. Both are caused by the d...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news